Cannell & Co. - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 68 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2023. The put-call ratio across all filers is 3.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cannell & Co. ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q1 2023$778,343
-0.8%
1,111,9190.0%0.03%0.0%
Q4 2022$785,015
-54.0%
1,111,919
-0.9%
0.03%
-56.9%
Q3 2022$1,705,000
+58.0%
1,121,919
+3.2%
0.06%
+66.7%
Q2 2022$1,079,000
-31.1%
1,086,9190.0%0.04%
-17.0%
Q1 2022$1,565,000
-72.4%
1,086,9190.0%0.05%
-70.8%
Q4 2021$5,674,000
-10.7%
1,086,919
-0.3%
0.16%
-17.0%
Q3 2021$6,354,000
-28.0%
1,089,919
-0.5%
0.19%
-26.5%
Q2 2021$8,825,000
-3.4%
1,094,919
-0.2%
0.26%
-7.7%
Q1 2021$9,131,000
+8.2%
1,097,419
-1.4%
0.29%
+2.1%
Q4 2020$8,438,000
-29.2%
1,113,239
-0.5%
0.28%
-36.1%
Q3 2020$11,923,000
-29.7%
1,118,4390.0%0.44%
-34.2%
Q2 2020$16,956,000
+85.8%
1,118,439
+2.1%
0.67%
+52.1%
Q1 2020$9,125,000
-50.7%
1,095,4390.0%0.44%
-33.3%
Q4 2019$18,513,000
-10.6%
1,095,439
-1.7%
0.66%
-16.3%
Q3 2019$20,701,000
-18.9%
1,114,739
-0.0%
0.78%
-18.7%
Q2 2019$25,517,000
+8.9%
1,115,2390.0%0.97%
+6.5%
Q1 2019$23,442,000
+82.8%
1,115,2390.0%0.91%
+61.4%
Q4 2018$12,825,000
-49.9%
1,115,2390.0%0.56%
-38.0%
Q3 2018$25,595,000
+2.9%
1,115,2390.0%0.91%
-2.6%
Q2 2018$24,870,000
-2.5%
1,115,239
-0.1%
0.93%
-3.2%
Q1 2018$25,511,000
-13.1%
1,116,439
-0.4%
0.96%
-4.9%
Q4 2017$29,356,000
+19.3%
1,120,439
+2.2%
1.01%
+18.3%
Q3 2017$24,611,000
-17.9%
1,096,2390.0%0.85%
-17.3%
Q2 2017$29,982,000
+13.0%
1,096,2390.0%1.03%
+10.4%
Q1 2017$26,529,000
+22.2%
1,096,239
+4.8%
0.94%
+19.1%
Q4 2016$21,709,000
-23.9%
1,046,2390.0%0.79%
-24.2%
Q3 2016$28,520,000
+89.4%
1,046,2390.0%1.04%
+89.2%
Q2 2016$15,055,000
+0.1%
1,046,2390.0%0.55%
+1.7%
Q1 2016$15,034,000
-29.0%
1,046,2390.0%0.54%
-21.5%
Q4 2015$21,169,000
+28.7%
1,046,239
+2.9%
0.69%
+28.4%
Q3 2015$16,452,000
-37.3%
1,016,8280.0%0.54%
-28.0%
Q2 2015$26,244,0001,016,8280.74%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Birchview Capital, LP 4,387,590$46,772,00015.62%
ORACLE INVESTMENT MANAGEMENT INC 4,091,749$43,618,0005.75%
GRIFFIN ASSET MANAGEMENT, INC. 1,439,613$15,346,0002.36%
Selkirk Management LLC 348,805$3,718,0001.18%
Chicago Capital, LLC 1,966,891$20,967,0001.08%
Trellus Management Company, LLC 46,834$499,0000.51%
Cannell & Co. 1,118,439$11,923,0000.44%
OAKTOP CAPITAL MANAGEMENT II, L.P. 155,000$1,652,0000.36%
Belpointe Asset Management LLC 419,406$3,982,0000.27%
TCI Wealth Advisors, Inc. 55,586$593,0000.23%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders